Profile for Coherus BioSciences, Inc. (CHRS)
« Back to company indexCHRS Chatter Timeline
Stock Ticker for CHRS
Most Active Tweeters for CHRS
| User | Tweets |
|---|---|
| @TheMarketsDaily | 6 |
| @dakotafinancial | 3 |
| @SPNewsAnalysis | 2 |
| @TickerReport | 2 |
| @IRAMarketReport | 2 |
Recent Tweets for CHRS
 |
@biotech_sector #CoherusBioSciences Coherus To Report Second Quarter 2017 Financial Results On August 7th . Read more: https://t.co/1FnskV237O $CHRS July 24th 2017, 2:07pm |
 |
@stockboardinc $CHRS Coherus BioSciences to Report Second Quarter 2017 Financial Results on August 7th... - https://t.co/Fp4TOVSS42 July 24th 2017, 9:07am |
 |
@GNWLive Coherus BioSciences to Report Second Quarter 2017 Financial Results on August 7th $CHRS https://t.co/sMuDOQ3olz July 24th 2017, 9:07am |
 |
@1MinuteStock Wondering about risks of $CHRS? The 63-day volatility is 38.89% https://t.co/KctqISSBuC July 22nd 2017, 1:07pm |
|
@1MinuteStock Unicorn Bay rating for $CHRS is 2.05 out of 5. https://t.co/xxbOsjUFrV July 22nd 2017, 12:07pm |
 |
@dakotafinancial 138,440 Shares in Coherus BioSciences, Inc. $CHRS Acquired by Principal Financial Group Inc. https://t.co/F8h1l9hitI July 22nd 2017, 8:07am |
 |
@IRAMarketReport Principal Financial Group Inc. Purchases New Position in Coherus BioSciences, Inc. $CHRS https://t.co/dP67g9BHV6 July 22nd 2017, 8:07am |
 |
@chaffeybreeze Principal Financial Group Inc. Purchases New Position in Coherus BioSciences, Inc. $CHRS https://t.co/uzoKvKrJG3 July 22nd 2017, 8:07am |
 |
@tsilver_apex $NVS planning resubmission of #biosimilar Neulasta for 2019 to address FDA CRL - seems $CHRS may still be first-to-market if all goes well July 18th 2017, 7:07am |
 |
@SPNewsAnalysis SG Americas Securities LLC Reduces Stake in Coherus BioSciences, Inc. $CHRS https://t.co/YGeMhLj0JS July 17th 2017, 9:07am |
 |
@emq_news SG Americas Securities LLC Reduces Stake in Coherus BioSciences, Inc. $CHRS https://t.co/I6sadoBmWK July 17th 2017, 5:07am |
 |
@TickerReport SG Americas Securities LLC Reduces Stake in Coherus BioSciences, Inc. $CHRS https://t.co/0v7khZEM6U July 17th 2017, 5:07am |
|
@TickerReport SG Americas Securities LLC Reduces Stake in Coherus BioSciences, Inc. $CHRS https://t.co/hb2ChA5Hh6 July 17th 2017, 5:07am |
 |
@TheMarketsDaily Coherus BioSciences, Inc. $CHRS Given New $37.00 Price Target at Robert W. Baird https://t.co/gNJFUM8bu6 July 15th 2017, 7:07pm |
 |
@DrSManian $CHRS Biosimilars hot area for M&A - solid management team - recent hire Pat Obrien from $GILD Will have a solid tu… https://t.co/jFduV40rDX July 15th 2017, 1:07pm |
|
@TheMarketsDaily Coherus BioSciences $CHRS Given Daily Media Impact Rating of 0.01 https://t.co/lh3LsbuUjN July 15th 2017, 9:07am |
|
@TheMarketsDaily Regeneron Pharmaceuticals $REGN & Coherus BioSciences $CHRS Critical Review https://t.co/fVZh73ZRxb July 14th 2017, 9:07pm |
|
@TheMarketsDaily Coherus BioSciences’ $CHRS Buy Rating Reaffirmed at J P Morgan Chase & Co https://t.co/O6pyQKGh43 July 14th 2017, 7:07pm |
|
@TheMarketsDaily Coherus BioSciences, Inc. $CHRS Earns “Outperform” Rating from Cowen and Company https://t.co/U2T1q2hUqU July 14th 2017, 7:07pm |
|
@chaffeybreeze Coherus BioSciences, Inc. $CHRS Receives $42.71 Average Price Target from Analysts https://t.co/chNKG5biYj July 14th 2017, 4:07am |
|
@IRAMarketReport Coherus BioSciences, Inc. $CHRS PT Lowered to $33.00 https://t.co/zcCnSIidXv July 14th 2017, 1:07am |
|
@TheMarketsDaily Coherus BioSciences, Inc. $CHRS Price Target Cut to $43.00 by Analysts at BMO Capital Markets https://t.co/iPOpUUOylp July 14th 2017, 1:07am |
|
@dakotafinancial Coherus BioSciences, Inc. $CHRS Shares Bought by Tudor Investment Corp ET AL https://t.co/tTgVsppnHB July 13th 2017, 12:07pm |
|
@SPNewsAnalysis Bank of New York Mellon Corp Has $3.49 Million Stake in Coherus BioSciences, Inc. $CHRS https://t.co/PiNnixGODW July 13th 2017, 8:07am |
 |
@storminvestor Bank of New York Mellon Corp Has $3.49 Million Stake in Coherus BioSciences, Inc. $CHRS https://t.co/rFoydtdbqI July 13th 2017, 8:07am |
 |
@midetimes Coherus BioSciences, Inc. $CHRS Shares Bought by Tudor Investment Corp ET AL https://t.co/8JSvkOyFkR July 13th 2017, 7:07am |
 |
@dailypoliticaln Bank of New York Mellon Corp Has $3.49 Million Stake in Coherus BioSciences, Inc. $CHRS https://t.co/qUfaKcgXsE July 13th 2017, 5:07am |
 |
@wboscoho Nibble some $CHRS even though biosimilars are not in vogue these days July 12th 2017, 2:07pm |
 |
@OncologyInfo Here's What's Behind Amgen, Inc.'s 10.2% Gain in June @themotleyfool #stocks $AMGN, $CHRS https://t.co/wTBJjr3moY July 12th 2017, 11:07am |
|
@dakotafinancial Coherus BioSciences, Inc. $CHRS Receives Consensus Recommendation of “Buy” from Analysts https://t.co/51zjeI8QpZ July 12th 2017, 12:07am |
 |
@Emylers CHRS Stock 13.38 Coherus Bio Cmn Stk $CHRS Hit 165,925 52 week lows as of +2.71%. Currently trading at 13.38 + https://t.co/BspgdSuX5c July 11th 2017, 11:07am |
 |
@MBAbstract Here's What's Behind Amgen, Inc.'s 10.2% Gain in June @themotleyfool #stocks $AMGN, $CHRS https://t.co/hA5bD7S55F July 10th 2017, 2:07pm |
 |
@langanstocks Emylers: CHRS Stock 13.15 Coherus Bio Cmn Stk $CHRS Hit 90,339 52 week lows as of +0.38%. Currently trading a https://t.co/BvaQYX2YmH July 10th 2017, 12:07pm |
|
@Emylers CHRS Stock 13.15 Coherus Bio Cmn Stk $CHRS Hit 90,339 52 week lows as of +0.38%. Currently trading at 13.15 -0 https://t.co/pDTYAGK9xz July 10th 2017, 11:07am |
|
@TheMarketsDaily Coherus BioSciences $CHRS Receiving Somewhat Positive Press Coverage, Study Finds https://t.co/dMfLabp3ZG July 10th 2017, 10:07am |
 |
@whotrades Here's What's Behind Amgen, Inc.'s 10.2% Gain in June https://t.co/N2M0zDzXXT $AMGN $CHRS July 10th 2017, 10:07am |
 |
@SleekMoneycom Coherus BioSciences $CHRS Receiving Somewhat Positive Press Coverage, Study Finds https://t.co/C3ADb2cbaC July 10th 2017, 7:07am |
|
@dakotafinancial Coherus BioSciences, Inc. $CHRS Shares Bought by Wells Fargo & Company MN https://t.co/3X9KThX7bp July 10th 2017, 7:07am |
|
@midetimes Coherus BioSciences, Inc. $CHRS Shares Bought by Wells Fargo & Company MN https://t.co/Sil34yjAfh July 10th 2017, 4:07am |
|
@midetimes Coherus BioSciences, Inc. $CHRS Given Average Rating of “Buy” by Analysts https://t.co/vToudcLwBd July 9th 2017, 5:07pm |
 |
@dailymailtimes Coherus BioSciences, Inc. $CHRS Given Average Rating of “Buy” by Analysts https://t.co/Vez98Enev2 July 9th 2017, 5:07pm |
|
@midetimes Highbridge Capital Management LLC Takes Position in Coherus BioSciences, Inc. $CHRS https://t.co/xbl8C5aMSd July 9th 2017, 8:07am |
|
@midetimes Coherus BioSciences, Inc. $CHRS Stake Boosted by Gotham Asset Management LLC https://t.co/4GsvFfF3QC July 9th 2017, 8:07am |
|
@storminvestor Coherus BioSciences, Inc. $CHRS Expected to Post Earnings of -$1.29 Per Share https://t.co/XqSfKsfP7j July 8th 2017, 6:07pm |
 |
@WatchlistN Coherus BioSciences, Inc. $CHRS Expected to Post Earnings of -$1.29 Per Share https://t.co/YeqYjjh0vP July 8th 2017, 6:07pm |
|
@SPNewsAnalysis Coherus BioSciences, Inc. $CHRS Expected to Post Earnings of -$1.29 Per Share https://t.co/ZgZ9EUPLbn July 8th 2017, 6:07pm |
 |
@BioPharmaDive $CHRS loses another partner on its Enbrel biosimilar https://t.co/YY9zsbA5H2 $AMGN July 8th 2017, 5:07pm |
 |
@TranscriptDaily Coherus BioSciences, Inc. $CHRS Receives $38.50 Average PT from Brokerages https://t.co/urq0WgxDZz July 7th 2017, 7:07pm |
|
@emq_news Coherus BioSciences, Inc. $CHRS Receives $38.50 Average PT from Brokerages https://t.co/FknNZ9Uumc July 7th 2017, 7:07pm |
|
@TickerReport Coherus BioSciences, Inc. $CHRS Receives $38.50 Average PT from Brokerages https://t.co/KWn9dPcOI4 July 7th 2017, 7:07pm |
Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.